No headlines found.
Sonim Technologies Public Entity Rebrands As DNA X, Inc., A Digital Asset Management Company
Newsfile (Tue, 27-Jan 4:30 PM ET)
Sonim Technologies Stockholders Approve Asset Sale to NEXA, Clearing Path for Strategic Transition
Newsfile (Wed, 31-Dec 8:31 AM ET)
PRNewswire (Tue, 16-Dec 10:23 AM ET)
DNA X Inc operates a digital asset management platform.
Dna X trades on the NASDAQ stock market under the symbol SONM.
As of March 6, 2026, SONM stock price declined to $4.64 with 12,900 million shares trading.
SONM has a beta of -0.11, meaning it tends to be less sensitive to market movements. SONM has a correlation of 0.00 to the broad based SPY ETF.
SONM has a market cap of $6.91 million. This is considered a Sub-Micro Cap stock.
In the last 3 years, SONM traded as high as $234.00 and as low as $2.52.
The top ETF exchange traded funds that SONM belongs to (by Net Assets): VXF.
SONM has underperformed the market in the last year with a price return of -87.7% while the SPY ETF gained +18.7%. SONM has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -26.2% and -6.6%, respectively, while the SPY returned -1.7% and -2.5%, respectively.
SONM support price is $4.56 and resistance is $5.53 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SONM shares will trade within this expected range on the day.
